Trials / Conditions / Refractory Colorectal Adenocarcinoma
Refractory Colorectal Adenocarcinoma
5 registered clinical trials studyying Refractory Colorectal Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cance NCT07147231 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encor NCT06102902 | National Cancer Institute (NCI) | Phase 1 |
| Withdrawn | Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer NCT04119830 | Roswell Park Cancer Institute | Phase 2 |
| Unknown | caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer. NCT06171854 | University of Campania Luigi Vanvitelli | Phase 2 |
| Active Not Recruiting | Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer NCT03087071 | M.D. Anderson Cancer Center | Phase 2 |